Construction of cis-Fused Hydrindane Skeleton with a Lactone Tether Utilizing Intramolecular Diels-Alder Reaction by Yin Shuqiang et al.
 This paper is dedicated to Professor Lutz F. Tietze on the occasion of his 75th birthday. 
HETEROCYCLES, Vol. 93, No. 1, 2016, pp. -. © 2016 The Japan Institute of Heterocyclic Chemistry   
Received, 31st August, 2015, Accepted, 17th September, 2015, Published online,  
DOI: 10.3987/COM-15-S(T)34 
 
CONSTRUCTION OF cis-FUSED HYDRINDANE SKELETON WITH A 
LACTONE TETHER UTILIZING INTRAMOLECULAR DIELS-ALDER 
REACTION 
Shuqiang Yin,a Kenji Takai,a Daishiro Minato,a Kenji Sugimoto,a Hideki 
Ohtsu,b Kiyoshi Tsuge,b and Yuji Matsuyaa,* 
aGraduate School of Medicine and Pharmaceutical Sciences, University of 
Toyama, 2630 Sugitani, Toyama 930-0194, Japan, bGraduate School of Science 
and Engineering, University of Toyama, 3190 Gofuku, Toyama 930-8555, Japan. 
E-mail: matsuya@pha.u-toyama.ac.jp  
Abstract – Synthetically important, cis-fused hydrindane skeleton having 
quaternary angular stereogenic centers was selectively furnished by 
intramolecular Diels-Alder reaction of ester-tethered precursor via endo transition 
state. The reaction was applicable for a construction of the steroidal BCD ring 
system with cis-hydrindane framework. 
Hydrindane skeletons, a 6/5-fused bicyclic system, have been widely found in biologically active 
compounds, representatively such as a steroidal CD ring.1 Many of the naturally occurring steroidal 
compounds have a trans stereochemistry on the CD ring juncture, and consequently, considerable efforts 
have been devoted for development of efficient construction methods of trans-hydrindane skeletons.2 
Among them, an intramolecular Diels-Alder approach has been explored for the predominant formation 
of the trans-hydrindanes (Scheme 1-a).3 In general, this approach preferentially gave the 
trans-hydrindane skeleton, and only minor cases have been reported for providing the cis-fused 
hydrindanes.4 On the other hand, the intermolecular Diels-Alder reaction between cyclopentenes and 
dienes are a promising and reliable approach for the formation of cis-hydrindanes due to the inherent 
stereospecificity of Diels-Alder reactions (Scheme 1-b).5,6 
 
Scheme 1. Reaction modes of Diels-Alder reaction 
 Hydrindanes having a cis stereochemistry have also been an important class of a substructure of bioactive 
natural compounds. For example, pinguisone showing antifeedant activity is a natural sesquiterpene 
possessing a furan-fused cis-hydrindane skeleton.7 Sarmentogenin and ouabagenin are aglycons of 
cardiac glycosides rhodexin A8 and ouabain,9 respectively, having unusual cis-fused AB and CD rings on 
their steroidal frameworks. Andrastins are meroterpenoids containing the cis-hydrindane substructure, 
and reported to inhibit the activity of the ras protein farnesyltransferase, thus being a promising lead 
compound for novel anticancer agents (Figure 1).10 All of these natural products commonly possess two 
quaternary carbons on the ring juncture of the cis-hydrindane. Therefore, use of sterically hindered 
tetra-substituted cyclopentenes as a dienophile is enforced in the forementioned intermolecular 
Diels-Alder strategy for the construction of cis-hydrindanes of such natural products. This means that 
dienes used in this strategy are often limited to sufficiently activated compounds such as Danishefsky’s 
dienes, and this situation is really found in the past literatures.11 In this paper, we describe the Diels-Alder 
reaction between highly electron-deficient tetra-substituted cyclopentene and unactivated dienes taking 
advantage of the intramolecular fashion using ester-tethered substrates of dienes and dienophiles, leading 
to a useful scaffold of natural compounds containing the cis-hydrindanes which have quaternary angular 
carbons. 
 
Figure 1. Natural compounds containing the cis-hydrindane substructure 
 
Methyl 2-methylcyclopenten-3-one-1-carboxylate (2a)12 is considered as a highly activated dienophile for 
Diels-Alder reaction. However, this compound has never used as a Diels-Alder dienophile with 
unactivated dienes probably due to steric congestion, although several examples have been reported that 
similar tetra-substituted cyclopentenone derivatives are conducted to intermolecular Diels-Alder reaction 
with dienes activated by one or more alkoxy substituents. In regard to the cycloaddition reaction of the 
compound 2a, photochemical [2+2] addition with allenes is only one example to the best of our 
knowledge.13 
In fact, the Diels-Alder reaction of 2a (R = Me) with the simple unactivated diene 1 did not proceed under 
thermal conditions in an intermolecular fashion in our hands. We then decided to try the corresponding 
intramolecular cycloaddition by using the ester-tethered substrate 3,14 which was prepared from the 
carboxylic acid 2b (R = H) and 2,4-hexadien-1-ol under dehydrative condensation conditions. 
 Gratifyingly, the intramolecular Diels-Alder reaction of the substrate 3 cleanly proceeded at 180 °C 
(sealed tube) to give the cis-hydrindane 4 in 91% yield. The reaction was endo selective (via endo-TS), 
which was confirmed by the NOE observation experiments (Scheme 2). 
 
 
Scheme 2. Successful Diels-Alder reaction for cis-hydrindane 
 
Encouraged by the above results, we applied this strategy for the construction of the steroidal BCD ring 
system with cis-hydrindane framework. The Diels-Alder substrate 9 was designed for this purpose, and 
synthesized according to Scheme 3. Commercially available cyclohexanedione 5 was converted to the 
iso-butyl enol ether 6 following the literature method,15 and the product 6 was allowed to react with 
trans-propenyl Grignard reagent followed by acidic hydrolysis to afford the dienone 7 in good yield. 
DIBAL reduction of 7 gave the alcohol 8, which was subjected to esterification with carboxylic acid 2 
using EDCI and DMAP to furnish the Diels-Alder substrate 9 in an efficient manner. 
 
 
Scheme 3. Preparation of a precursor for steroidal BCD ring system with cis-hydrindane framework 
 
 With the substrate compound 9 in hand, we investigated optimal conditions for the intramolecular 
Diels-Alder reaction to establish the lactone-tethered tricyclic system formation (Table 1). Although the 
reaction did not proceed under toluene reflux condition (entry 1), the desired cycloadducts were formed in 
refluxing xylene in low yield (entry 2). Favorably the reaction was largely improved at 145 °C in a sealed 
tube to realize 73% yield, whose endo/exo ratio was 53/20 (entry 3). The reaction was found to be highly 
susceptible to the temperature, and the yield was decreased at 160 °C (entry 4) and considerable 
decomposition was observed in short time at 180 °C in o-dichlorobenzene (entry 5). The stereostructure 
of the product 10a was unambiguously determined by X-ray crystallography (Figure 2) to be an 
endo-adduct, which was predominant product via the similar endo transition state in the case of Scheme 
2.16 Thus, the best condition of the intramolecular Diels-Alder reaction of 9 was established, and efficient 
approach for the tetracyclic framework 10 including the cis-hydrindane and the ester tether was 
accomplished. These compounds would be versatile scaffolds for bioactive natural compounds containing 
the cis-hydrindane substructure. 
 
Table 1. Diels-Alder Reaction for steroidal BCD ring with cis-hydrindane framework 
 
 
Figure 2. ORTEP drawing of the endo-adduct 10a 
 
 In this paper, we have described the efficient intramolecular Diels-Alder strategy for the cis-hydrindane 
skeleton construction, between highly congested tetra-substituted cyclopentenone and unactivated dienes 
using ester-tethered substrates of dienes and dienophiles. These reactions would serve for providing 
useful scaffolds of various compounds containing the cis-hydrindanes having quaternary angular carbons 
such as illustrated in Figure 1. Further applications of these reactions for natural product syntheses are 
now under investigation in our laboratory. 
 
EXPERIMENTAL 
All nonaqueous reactions were carried out under an Ar atmosphere. Reagents were purchased from 
commercial suppliers and used as received. Anhydrous solvents were prepared by distillation over CaH2, 
or purchased from commercial suppliers. 1H and 13C NMR spectra were measured on a JEOL ECX 400 or 
a Varian GEMINI 300 instrument, using CHCl3 (7.26 ppm for 1H) and CDCl3 (77.0 ppm for 13C) as an 
internal reference. The following abbreviations are used for spin multiplicity: s = singlet, d = doublet, t = 
triplet, q = quartet, m = multiplet, and br = broad. J values were in hertz. Mass spectra were measured on 
a JEOL JMS-GCmate II or a JEOL JMS-AX 505 HAD mass spectrometer, and the ionization method was 
electron impact (EI, 70 eV). IR spectra were recorded on a JASCO FT/IR-460Plus spectrometer. Column 
chromatography was carried out by employing Cica Silica Gel 60N (spherical, neutral, 40-50 μm). 
(2E,4E)-Hexadienyl 2-Methyl-3-oxo-cyclopent-1-ene-1-carboxylate (3). To a stirred solution of the 
carboxylic acid 2b (440 mg, 3.14 mmol) in CH2Cl2 (15 mL) were added DMAP (192 mg, 1.57 mmol), 
EDCI (900 mg, 4.70 mmol), and 2,4-hexadien-1-ol (463 mg, 4.70 mmol) at room temperature. After 
stirred for 24 h at the same temperature, the mixture was concentrated in vacuo. The residue was purified 
by flash column chromatography on silica gel (eluent: hexane/AcOEt = 20:1) to give the ester 3 (581 mg, 
84%) as a colorless oil. 
1H NMR (300 MHz, CDCl3) δ 6.35–6.27 (1H, m), 6.12–6.03 (1H, m), 5.84–5.63 (2H, m), 4.76 (2H, d, J 
= 6.9 Hz), 2.79–2.74 (2H, m), 2.48–2.45 (2H, m), 2.05 (3H, s), 1.77 (3H, d, J = 6.6 Hz); 13C NMR (75 
MHz, CDCl3) δ 209.3, 165.0, 154.1, 147.1, 135.4, 131.6, 130.1, 122.8, 65.5, 33.8, 26.4, 18.1, 9.9; IR 
(neat) 2929, 1700, 1447 cm–1; MS (EI) m/z 220 (M+); HRMS (EI) calcd for C13H16O3 (M+) 220.1100, 
found 220.1095. 
6,6a-Dimethyl-3,3a,6,6a,8,9-hexahydro-1H,7H-indeno[3a,4-c]furan-1,7-dione (4). A stainless sealed 
tube including a solution of the ester 3 (25.0 mg, 0.114 mmol) and BHT (2.5 mg, 0.0114 mmol) in 
toluene (1.1 mL) was heated at 180 °C for 24 h. After removal of the solvent in vacuo, the residue was 
purified by flash column chromatography on silica gel (eluent: hexane/AcOEt = 5:1) to give the lactone 4 
(23.0 mg, 91%) as a white solid. 
 1H NMR (400 MHz, CDCl3) δ 5.89–5.86 (1H, m), 5.77–5.74 (1H, m), 4.51–4.48 (1H, m), 4.15–4.10 (1H, 
m), 3.11–3.05 (1H, m), 2.39–2.31 (1H, m), 2.16–2.01 (3H, m), 1.87–1.82 (1H, m), 1.21 (3H, s), 0.99 (3H, 
d, J = 7.8 Hz); 13C NMR (100 MHz, CDCl3) δ 217.0, 176.5, 136.5, 123.1, 67.6, 54.2, 52.3, 40.3, 39.9, 
34.3, 23.1, 17.8, 17.1; IR (neat) 2978, 1757, 1734 cm–1; MS (EI) m/z 220 (M+); HRMS (EI) calcd for 
C13H16O3 (M+) 220.1100, found 220.1092; Mp 141–143 °C. 
3-Isobutyl-6,6-dimethylcyclohex-2-en-1-one (6). To a stirred solution of 
4,4-dimethylcyclohexane-1,3-dione (5.00 g, 35.6 mmol) in benzene (100 mL) were added p-TsOH (355 
mg, 1.86 mmol) and i-BuOH (6.7 mL, 72.5 mmol) at room temperature. After reflux with Dean-Stark 
apparatus for 15 h, the reaction mixture was diluted with Et2O and the reaction was quenched with 
saturated aqueous NaHCO3. The water phase was extracted with Et2O and the combined organic extracts 
were washed with brine, dried over MgSO4, filtered, and concentrated in vacuo. The residue was purified 
by flash column chromatography on silica gel (eluent: hexane/AcOEt = 3:1) to give the vinylogous ester 6 
(5.57 g, 80%) as a pale yellow oil. 
1H NMR (300 MHz, CDCl3) δ 5.23 (1H, s), 3.58 (2H, d, J = 6.6 Hz), 2.43 (2H, t, J = 5.8 Hz), 2.17–2.15 
(1H, m), 1.80 (2H, t, J = 6.3 Hz), 1.15 (6H, s), 0.98 (6H, d, J = 6.6 Hz); 13C NMR (75 MHz, CDCl3) δ 
204.2, 175.8, 100.8, 74.4, 39.9, 34.8, 27.5, 26.0, 24.4, 18.9; IR (neat) 1655, 1611 cm–1; HRMS (EI) calcd 
for C12H20O2 (M+) 196.1463, found 196.1463. 
(E)-4,4-Dimethyl-3-(prop-1-en-1-yl)cyclohex-2-en-1-one (7). To a stirred suspension of Mg (604 mg, 
24.9 mmol) in THF (48 mL) was added trans-propenyl bromide (2.1 mL, 24 mmol) at room temperature 
and heated at reflux for 1.5 h. To a solution of the vinylogous ester 6 (201 mg, 1.02 mmol) in THF was 
added the above Grignard reagent (0.5 M in THF, 6.2 mL, 3.06 mmol) at 0 °C. After stirred for 80 min at 
room temperature, 10% aqueous HCl was added to the mixture at 0 °C. After stirred for 5 min at the same 
temperature, the water phase was extracted with Et2O. The combined organic phases were washed with 
brine, dried over MgSO4, filtered, and concentrated in vacuo. The residue was purified by flash column 
chromatography on silica gel (eluent: hexane/AcOEt = 5:1) to give the dienone 7 (112 mg, 66%) as a pale 
yellow oil. 
1H NMR (300 MHz, CDCl3) δ 6.26–6.08 (2H, m), 5.97 (1H, s), 2.43–2.38 (2H, m), 1.85–1.81 (5H, m), 
1.16 (6H, s) ; 13C NMR (75 MHz, CDCl3) δ 199.4, 166.3, 132.6, 127.8, 121.5, 37.5, 34.6, 34.3, 26.8, 
19.0; IR (neat) 1665 cm–1; MS (EI) m/z 164 (M+); HRMS (EI) calcd for C11H16O (M+) 164.1201, found 
164.1203. 
(E)-4,4-Dimethyl-3-(prop-1-en-1-yl)cyclohex-2-en-1-ol (8). To a stirred solution of the dienone 7 (51.7 
mg, 0.314 mmol) in CH2Cl2 (2.0 mL) was added DIBAL (1.0 M in toluene, 0.9 mL, 0.9 mmol) at 0 °C. 
After stirred for 15 min at the same temperature, the reaction was quenched with saturated aqueous 
NH4Cl at 0 °C. The filtrate was washed with brine, dried over Na2SO4, filtered, and concentrated in vacuo. 
 The residue was purified by flash column chromatography on silica gel (eluent: hexane/AcOEt = 2:1) to 
give the alcohol 8 (50.2 mg, 96%) as a colorless oil. 
1H NMR (300 MHz, CDCl3) δ 5.96 (1H, d, J = 15.3 Hz), 5.89–5.80 (1H, m), 5.65 (1H, d, J = 3.3 Hz), 
4.18 (1H, br s), 1.92–1.84 (1H, m), 1.74 (3H, d, J = 6.3 Hz), 1.60–1.38 (4H, m), 1.06 (3H, s), 1.00 (3H, 
s); 13C NMR (75 MHz, CDCl3) δ 147.0, 129.4, 126.1, 123.1, 66.7, 35.6, 33.7, 29.0, 28.0, 27.8, 18.5; IR 
(neat) 3329 cm–1; MS (EI) m/z 166 (M+); HRMS (EI) calcd for C11H18O (M+) 166.1358, found 166.1380. 
(E)-4,4-Dimethyl-3-(prop-1-en-1-yl)cyclohex-2-en-1-yl-2-methyl-3-oxo-cyclopent-1-ene-1-carboxyl- 
ate (9). To a solution of carboxylic acid 2b (108 mg, 0.774 mmol) and alcohol (82.7 mg, 0.497 mmol) in 
CH2Cl2 (5.0 mL) were added EDCI (195 mg, 1.02 mmol) and HOBt·H2O (30.4 mg, 0.249 mmol) at room 
temperature. After stirred for 35 min, the mixture was diluted with CH2Cl2 and the organic phase was 
washed with saturated aqueous NaHCO3 and 10% aqueous citric acid, dried over MgSO4, filtered, and 
concentrated in vacuo. The residue was used for the next reaction without further purification because of 
instability against column chromatography on silica gel. 
1H NMR (300 MHz, CDCl3) δ 5.96 (1H, d, J = 16.5 Hz), 5.93–5.82 (1H, m), 5.69 (1H, d, J = 3.8 Hz), 
5.42 (1H, q, J = 4.7 Hz), 2.79–2.73 (2H, m), 2.47–2.44 (2H, m), 2.03 (3H, s), 2.00–1.92 (1H, m), 1.83–
1.78 (1H, m), 1.75 (3H, d, J = 6.1 Hz), 1.71–1.63 (1H, m), 1.58–1.46 (1H, m), 1.10 (3H, s), 1.03 (3H, s); 
13C NMR (75 MHz, CDCl3) δ 209.7, 165.1, 154.9, 149.7, 128.8, 127.1, 117.6, 70.3, 35.1, 33.8, 33.5, 27.9, 
27.3, 26.4, 25.1, 18.4, 9.9; IR (neat) 1713, 1645, 1570 cm–1; MS (EI) m/z 288 (M+); HRMS (EI) calcd for 
C18H24O3 (M+) 288.1726, found 288.1753. 
8,8,10,10a-Tetramethyl-2,3,5a,6,7,8,10,10a-octahydro-4H-cyclopenta[7,8]naphtha-[1,8-bc]furan-1,4(
3a1H)-dione (10a and 10b). A stainless sealed tube including a solution of the ester 9 (30.2 mg, 0.104 
mmol) in xylene (0.9 mL) was heated at 145 °C for 18 h. After removal of the solvent in vacuo, the 
residue was purified by flash column chromatography on silica gel (eluent: hexane/AcOEt = 4:1) to give 
the lactones 10a (16.0 mg, colorless prism, 53%) and 10b (5.9 mg, pale yellow prism, 20%). 
10a: 1H NMR (300 MHz, CDCl3) δ 5.43 (1H, t, J = 2.5 Hz), 4.70–4.62 (1H, m), 3.14 (1H, d, J = 8.5 Hz), 
2.48–2.34 (1H, m), 2.15–1.99 (1H, m), 1.96–1.88 (4H, m), 1.64–1.52 (3H, m), 1.20 (6H, s), 1.15 (3H, s), 
1.01 (3H, d, J = 7.6 Hz); 13C NMR (75 MHz, CDCl3) δ 217.4, 176.6, 146.9, 128.2, 77.0, 56.4, 53.2, 43.0, 
42.4, 36.4, 34.9, 33.6, 32.5, 29.5, 29.4, 26.0, 18.0, 16.5; IR (neat) 1761, 1734 cm–1; MS (EI) m/z 288 
(M+); HMRS (EI) calcd for C18H24O3 (M+) 288.1726, found 288.1758; Mp 175–177 °C. 
10b: 1H NMR (300 MHz, CDCl3) δ 5.47 (1H, t, J = 3.0 Hz), 4.72–4.65 (1H, m), 2.77–2.64 (2H, m), 
2.49–2.27 (3H, m), 2.19–2.11 (1H, m), 2.08–2.01 (1H, m), 1.63–1.48 (2H, m), 1.35–1.29 (1H, m), 1.12 
(6H, s), 1.01 (3H, s), 0.98 (3H, d, J = 7.1 Hz); 13C NMR (75 MHz, CDCl3) δ 216.0, 178.8, 138.8, 126.3, 
76.7, 53.2, 52.6, 41.6, 34.6, 34.5, 33.2, 31.4, 29.8, 28.8, 25.7, 16.6, 14.1; IR (neat) 1750 cm–1; MS (EI) 
m/z 288 (M+); HRMS (EI) calcd for C18H24O3 (M+) 288.1726, found 288.1699; Mp 156–158 °C. 
 Deposition number CCDC-1421053 for compound 10a. Free copies of the data can be obtained via 
http://www.ccdc.cam.ac.uk/conts/retrieving.html (or from the Cambridge Crystallographic Data Centre, 
12 Union Road, Cambridge, CB2 1EZ, UK; Fax: +44 1223 336033; e-mail: deposit@ccdc.cam.ac.uk). 
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